All Publications


  1. Community-acquired acute bacterial meningitis in the elderly in Turkey. Clin Microbiol Infect 2010; 16: 1223–9.
  2. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs. Ann Clin Microbiol Antimicrob 2011; 10. DOI:10.1186/1476-0711-10-38.
  3. Management of Brucella endocarditis: Results of the Gulhane study. Int J Antimicrob Agents 2012; 40: 145–50.
  4. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: Results of the Istanbul study. Antimicrob Agents Chemother 2012; 56: 1523–8.
  5. The place and the efficacy of infectious disease consultations in the hospitals. Infect Dis Clin Pract 2012; 20: 131–6.
  6. Infectious diseases departments and patients in the University Hospitals in Turkey. J Infect Dis Ther 2013; 1: 22–7.
  7. Withdrawal of Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control 2013; 41: 1053–8.
  8. Mortality indicators in community-acquired pneumonia requiring intensive care in Turkey. Int J Infect Dis 2013; 17: e768–72.
  9. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: Risk factors for mortality. J Crit Care 2013; 28: 975–979.
  10. Diagnosis of chronic brucellar meningitis and meningoencephalitis: The results of the Istanbul-2 study. Clin Microbiol Infect 2013; 19: E80–6.
  11. Emergence and Coinfections of West Nile virus and Toscana Virus in Eastern Thrace, Turkey. Clin Microbiol Infect 2014; 20: 319–25.
  12. The microbiological diagnosis of tuberculous meningitis: Results of Haydarpasa-1 study. Clin Microbiol Infect 2014; 20: O847–O853.
  13. The features of infectious diseases departments and anti-infective practices in France and Turkey: A cross-sectional study. Eur J Clin Microbiol Infect Dis 2014; 33: 1591–9.
  14. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran – A prospective multicenter point prevalence study. J Infect 2014; 68: 131–40.
  15. Mortality indicators in pneumococcal meningitis: Therapeutic implications. Int J Infect Dis 2014; 19: 13–9.
  16. Genitourinary brucellosis: Results of a multicentric study. Clin Microbiol Infect 2014; 20: O847–O853.
  17. Liver involvement in patients with brucellosis: Results of the Marmara study. Eur J Clin Microbiol Infect Dis 2014; 33: 1253–62.
  18. Evaluation of tularaemia courses: A multicentre study from Turkey. Clin Microbiol Infect 2014; 20: O1042–O1051.
  19. Update on treatment options for spinal brucellosis. Clin Microbiol Infect 2014; 20: O75–O82.
  20. The interrelations of radiologic findings and mechanical ventilation in community acquired pneumonia patients admitted to the intensive care unit: A multicentre retrospective study. Ann Clin Microbiol Antimicrob 2014; 13. DOI:10.1186/1476-0711-13-5.
  21. Respiratory system involvement in brucellosis: The results of the Kardelen Study. Chest 2014; 145: 87–94.
  22. Tuberculous and brucellosis meningitis differential diagnosis. Travel Med Infect Dis 2015; 13: 185–91.
  23. Comparison of brucellar and tuberculous spondylodiscitis patients: Results of the multicenter ‘Backbone-1 Study’. Spine J 2015; 15: 2509–2517 C.
  24. Antituberculosis drug resistance patterns in adults with tuberculous meningitis: Results of Haydarpasa-IV study. Ann Clin Microbiol Antimicrob 2015; 14: 1–6.
  25. Results of a Multinational Study Suggest the Need for Rapid Diagnosis and Early Antiviral Treatment at the Onset of Herpetic Meningoencephalitis. Antimicrob Agents Chemother 2015; 59: 3084–9.
  26. The course of spinal tuberculosis (Pott disease): Results of the multinational, multicentre Backbone-2 study. Clin Microbiol Infect 2015; 21: 1008.e9-1008.e18.
  27. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study. J Neurol 2015; 262: 890–8.
  28. Hydrocephalus and vasculitis delay therapeutic responses in tuberculous meningitis: Results of Haydarpasa-III study. Neurol India 2016; 64: 896‑905.
  29. Managing atypical and typical herpetic central nervous system infections: results of a multinational study. Clin Microbiol Infect 2016; 22: 568.e9–568.e17.
  30. Infections in travellers returning to Turkey from the Arabian Peninsula: a retrospective cross-sectional multicenter study. Eur J Clin Microbiol Infect Dis 2016; 35: 903–10.
  31. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study. Infection 2016; 44: 623–31.
  32. Quality of life and related factors among chronic hepatitis B-infected patients: A multi-center study, Turkey. Health Qual Life Outcomes 2016; 14: 153.
  33. The burden and epidemiology of community-acquired central nervous system infections: a multinational study. Eur J Clin Microbiol Infect Dis 2017; 36: 1595–611.
  34. Central nervous system infections in the absence of cerebrospinal fluid pleocytosis. Int J Infect Dis 2017; 65: 107–9.
  35. Tetanus in adults: results of the multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 2017; 36: 1455–62.
  36. Other Foci of Infections in Community-Acquired Central Nervous System Infections. J Meningitis 2017; 1: 8–10.
  37. Community-acquired infections among refugees leading to Intensive Care Unit admissions in Turkey. Int J Infect Dis 2017; 58: 111–4.
  38. Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study. Eur J Clin Microbiol Infect Dis 2018; 37: 1231–40.
  39. Radiological data in microbiologically confirmed central nervous system tuberculosis. Clin Microbiol Infect 2018; 24: 1109–10.
  40. Predictors of unfavorable outcomes in neurosyphilis: Multicenter ID-IRI Study. Eur J Clin Microbiol Infect Dis 2019;38(1):125-134.
  41. Infection control bundles in intensive care: an international cross-sectional survey in low- and middle-income countries. J Hosp Infect 2019; 101: 248–56.
  42. Portraying infective endocarditis: Results of multinational ID-IRI study. Eur J Clin Microbiol Infect Dis 2019; 38: 1753–63.
  43. Brucellosis in pregnancy: results of multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 2019; 38: 1261–8.
  44. Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 2020; 39: 45–52.
  45. Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection – Result of a multinational ID-IRI study. J Clin Virol 2020; 122: 104213.
  46. A novel ID-IRI score: development and internal validation of the multivariable community-acquired sepsis clinical risk prediction model. Eur J Clin Microbiol Infect Dis 2020; 39: 689–701.
  47. Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study. Eur J Clin Microbiol Infect Dis 2020; 39: 493–500.
  48. Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): A snapshot ID-IRI survey” Journal of Antimicrobial Chemotherapy. 2020; 75(11): 3386-3390.
  49. The diagnostic utility of the Lancet and Thwaites Criteria in Tuberculous vs. Non-tuberculous Subacute Meningitis: Multicenter Analysis of 395 adult patients. BMC Infectious Diseases 2020;20:788
  50. Health Care Worker Infections and Deaths due to COVID-19: A Survey from 37 Nations and a Call for WHO to Post National Data on their Website.  International Journal of Infectious Diseases 2021; 102: 239-24
  51. Managing adult patients with infectious diseases in emergency departments: International ID-IRI Study. Journal of Chemotherapy 2021;33(5):302-318.
  52. Anxiety among front-line health-care workers supporting patients with Covid-19: A global survey. General Hospital Psychiatry 2020; 68:90-96.
  53. Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an International ID-IRI survey. European Journal of Clinical Microbiology & Infectious Diseases 2021; 40(11): 2323-2334.
  54. International multicentre study of Candida auris infections. Journal of Fungi 2021 19;7(10):878. 
  55. Vector-Borne and Zoonotic Infections and Their Relationships with Regional and Socioeconomic Statuses: A survey in 24 Countries of Europe, Africa, and Asia. Travel Medicine and Infectious Disease 2021 Nov-Dec;44:102174. 
  56. Survival in Rhino-Orbito-Cerebral Mucormycosis: An International, Multicenter ID-IRI Study. European Journal of Internal Medicine 2022;100:56-61.
  57. The COVID-19 vaccination acceptance/hesitancy rate and its determinants among HCWs of 91 Countries, a multicenter cross-sectional study.  EXCLI Journal 2022;21:93-103 
  58. Vaccine hesitancy and refusal among parents: An international ID-IRI survey. Journal of Infection in Developing countries 2022; 16(6):1081-1088.
  59. Analyzing CLABSI prevention bundles in 22 countries: The results of ID-IRI Survey. American Journal of Infection Control 2022 Dec;50(12):1327-1332.
  60. Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey. Journal of Infection and Public Health 2022 Sep;15(9):950-954. 
  61. Factors Leading to Dissemination of Cutaneous Anthrax: An International ID-IRI Study. New Microbes and New Infections2022 Sep 7;48:101028.
  62. Classical Fever of Unknown Origin in 21 Countries with Different Economic Development: An International ID-IRI Study. European Journal of Clinical Microbiology and Infectious Diseases 2023;42(4):387-398.
  63. Prospective analysis of febrile neutropenia patients with bacteraemia: The results of ID-IRI study. International Journal of Antimicrobial Agents (In press)
  64. Eser-Karlidag G, Chacon-Cruz E, Cag Y, et al. Features of Mpox Infection: The analysis of the data submitted to the ID-IRI network. New Microbes and New Infections (In press)